HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) Supplemental Data All Versions of this Article: T500024-MCP200v1 5/4/749    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Glossary Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kinoshita, E. Articles by Koike, T. Search for Related Content PubMed PubMed Citation Articles by Kinoshita, E. Articles by Koike, T. Social Bookmarking                      What's this?

Molecular & Cellular Proteomics 5:749-757, 2006.
© 2006 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Technology

Phosphate-binding Tag, a New Tool to Visualize Phosphorylated Proteins^*,S

Eiji Kinoshita^,,¶, Emiko Kinoshita-Kikuta, Kei Takiyama and Tohru Koike^,,||

From the Department of Functional Molecular Science, Graduate School of Biomedical Sciences, and Frontier Center for Microbiology, Hiroshima University, Kasumi 1-2-3, Hiroshima 734-8551, Japan

	ABSTRACT

TOP ABSTRACT EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

 
We introduce two methods for the visualization of phosphorylated proteins using alkoxide-bridged dinuclear metal (i.e. Zn²⁺ or Mn²⁺) complexes as novel phosphate-binding tag (Phos-tag) molecules. Both Zn²⁺- and Mn²⁺-Phos-tag molecules preferentially capture phosphomonoester dianions bound to Ser, Thr, and Tyr residues. One method is based on an ECL system using biotin-pendant Zn²⁺-Phos-tag and horseradish peroxidase-conjugated streptavidin. We demonstrate the electroblotting analyses of protein phosphorylation status by the phosphate-selective ECL signals. Another method is based on the mobility shift of phosphorylated proteins in SDS-PAGE with polyacrylamide-bound Mn²⁺-Phos-tag. Phosphorylated proteins in the gel are visualized as slower migration bands compared with corresponding dephosphorylated proteins. We demonstrate the kinase and phosphatase assays by phosphate affinity electrophoresis (Mn²⁺-Phos-tag SDS-PAGE).

Recently we have reported that a dinuclear metal complex (i.e. 1,3-bis[bis(pyridin-2-ylmethyl)amino]propan-2-olato dizinc(II) complex) acts as a novel phosphate-binding tag (Phos-tag)¹ (commercially available at www.phos-tag.com) in an aqueous solution at a neutral pH (e.g. K_d = 25 nM for phenyl phosphate dianion) (4). The Phos-tag (see Fig. 1) has a vacancy on two metal ions that is suitable for the access of a phosphomonoester dianion as a bridging ligand. The resulting 1:1 phosphate-binding complex, ROPO₃^2–-(Zn²⁺-Phos-tag)³⁺, has a total charge of +1. The anion selectivity indexes of the phenyl phosphate dianion against SO₄^2–, CH₃COO^–, Cl^–, and the bisphenyl phosphate monoanion at 25 °C are 5.2 x 10³, 1.6 x 10⁴, 8.0 x 10⁵, and >2 x 10⁶, respectively. These findings have contributed to the development of procedures for MALDI-TOF-MS for the analysis of phosphorylated compounds (e.g. phosphopeptides and phospholipids) (5–7), IMAC for the separation of phosphopeptides and phosphorylated proteins (8), and surface plasmon resonance (SPR) analysis for reversible peptide phosphorylation (9). In this study, we demonstrated two novel applications of the Phos-tag molecules. One is the chemiluminescence detection of whole phosphorylated proteins on electroblotting membranes using biotinylated Zn²⁺-Phos-tag and HRP-SA. Another is simple SDS-PAGE for the separation of a phosphorylated protein and the corresponding nonphosphorylated one where polyacrylamide-bound Mn²⁺-Phos-tag was used as a phosphate-binding moiety.

View larger version (20K): [in this window] [in a new window]   FIG. 1. Structures of biotin-pendant and acrylamide-pendant Phos-tag ligands and scheme of the reversible capturing of a phosphomonoester dianion (ROPO32–) by Zn2+-Phos-tag and Mn2+-Phos-tag.

	EXPERIMENTAL PROCEDURES

TOP ABSTRACT EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

Apparatus—
IR spectrum was recorded on a Horiba FT-710 infrared spectrometer with a KCl pellet (Real Crystal IR Card) at 20 ± 2 °C. ¹H (500-MHz) and ¹³C (125-MHz) NMR spectra at 25.0 ± 0.1 °C were recorded on a JEOL LA500 spectrometer. Tetramethylsilane (in CDCl₃) (Merck) was used as an internal reference for ¹H and ¹³C NMR measurements. MALDI-TOF-MS spectra (positive reflector mode) were obtained on a Voyager RP-3 BioSpectrometry work station (PerSeptive Biosystems) equipped with a nitrogen laser (337 nm, 3-ns pulse). Time-to-mass conversion was achieved by external calibrations using peaks for -cyano-4-hydroxycinnamic acid (m/z 190.05 for M + H⁺) and a peptide, Ac-Ile-Tyr-Gly-Glu-Phe-NH₂ (m/z 691.31 for M + Na⁺). The pH measurement was conducted with a Horiba F-12 pH meter (Kyoto, Japan) and a combination pH electrode (Horiba-6378), which was calibrated using pH standard buffers (pH 4.01 and 6.86) at 25 °C. Fluorescence gel images were acquired on an FLA 5000 laser scanner (Fujifilm, Tokyo, Japan). Pro-Q Diamond dye (10) was detected by 532-nm excitation with a 575-nm bandpass emission filter. SYPRO Ruby dye (11) was detected by 473-nm excitation with a 575-nm bandpass emission filter. A LAS 3000 image analyzer (Fujifilm) was used for the observation of chemiluminescence.

Synthesis of Acrylamide-pendant Phos-tag Ligand—
Amino-pendant Phos-tag ligand (N-(5-(2-aminoethylcarbamoyl)pyridin-2-ylmetyl)-N,N',N'-tris(pyridin-2-yl-methyl)-1,3-diaminopropan-2-ol) was synthesized as described previously (8). A CH₂Cl₂ solution (5 ml) of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (92 mg, 0.48 mmol) was added dropwise to a solution of N-(5-(2-aminoethylcarbamoyl)pyridin-2-ylmetyl)-N,N',N'-tris(pyridin-2-yl-methyl)-1,3-diaminopropan-2-ol (0.21 g, 0.40 mmol), acrylic acid (35 mg, 0.48 mmol), and 4-methoxyphenol (0.30 mg) in 15 ml of CH₂Cl₂ at 0 °C for 5 min. The reaction mixture was stirred for 3 h at room temperature under a nitrogen atmosphere. After the solvent had been evaporated, the residue was dissolved in 100 ml of CHCl₃. The CHCl₃ solution was washed with 0.5 M HEPES-NaOH buffer (pH 7.8, 50 ml x 5) and evaporated. The residue was purified by silica gel column chromatography (eluent, CH₂Cl₂/MeOH = 50:0 to 50:1) to obtain acrylamide-pendant Phos-tag ligand (N-(5-(2-acryloylaminoethylcarbamoyl)pyridin-2-ylmetyl)-N,N',N'-tris(pyridin-2-yl-methyl)-1,3-diaminopropan-2-ol) as a pale yellow oil (124 mg, 0.21 mmol, 53% yield). TLC (eluent, CH₃CN/MeOH/28% aqueous NH₃ = 4:1:1) R_f = 0.70. IR (cm^–1): 3263, 3061, 2928, 2828, 1652, 1594, 1569, 1539, 1478, 1436, 1408, 1365, 1316, 1248, 1150, 1122, 1094, 1048, 983, 806, 763, 733. ¹H NMR (CDCl₃): 2.56–2.69 (4H, m, NCCCHN), 3.57–3.66 (4H, m, CONCCH and CONCHC), 3.80–3.94 (9H, m, NCCHCN and PyCHN), 5.65 (1H, d, J = 10.3 Hz, COC=CH), 6.11 (1H, dd, J = 17.0 and 10.3 Hz, COCH=C), 6.29 (1H, d, J = 17.0 Hz, COC=CH), 6.60 (1H, bs, NHCOC = C), 7.13 (3H, t, J = 6.2 Hz, PyH), 7.34 (3H, d, J = 7.8 Hz, PyH), 7.44 (2H, d, J = 8.0 Hz, PyH), 7.59 (3H, td, J = 7.7 and 1.8 Hz, PyH), 7.73 (1H, bs, PyCONH), 7.99 (1H, dd, J = 8.0 and 2.3 Hz, PyH), 8.50 (3H, d, J = 4.3 Hz, PyH), 8.90 (1H, d, J = 1.8 Hz, PyH). ¹³C NMR (CDCl₃): 39.7, 41.0, 58.9, 60.5, 60.8, 67.2, 122.0, 122.6, 123.0, 126.7, 128.0, 130.5, 135.4, 136.4, 147.7, 148.78, 148.83, 159.0, 159.2, 162.6, 166.4, 167.1. MALDI-TOF-MS: metal-free ligand (HL) in a 50% (v/v) CH₃CN solution containing 2',4',6'-trihydroxyacetophenone (5 mg/ml); m/z 595.3 for M + H⁺, 1:1 phosphate-bound dizinc(II) complex (Zn₂L³⁺-HOPO₃^2–) in a 50% (v/v) CH₃CN solution containing 2',4',6'-trihydroxyacetophenone (5 mg/ml), 1.0 mM Zn(CH₃COO)₂, 0.50 mM HL, and 5.0 mM NaH₂PO₄-NaOH (pH 6.9); m/z 817.1, 1:1 phenyl phosphate-bound dimanganese(II) complex (Mn₂L³⁺-PhOPO₃^2–) in a 50% (v/v) acetone solution containing Harmane (5 mg/ml), 0.40 mM MnCl₂, 0.20 mM HL, 0.20 mM disodium phenyl phosphate, and 10 mM boric acid-NaOH (pH 9.0); m/z 875.2.

Preparation of a Complex of Biotin-pendant Zn²⁺-Phos-tag and HRP-conjugated Streptavidin—
A MeOH solution of a biotin-pendant Phos-tag ligand (0.10 M) was diluted with an aqueous solution containing 10 mM Tris-HCl (pH 7.5), 0.10 M NaCl, and 0.1% (v/v) Tween 20 (TBS-T solution) by a factor of 10. The obtained solution of the 10 mM biotin-pendant Phos-tag ligand (solution L) was stored at room temperature. To prepare the 4:1 complex of biotin-pendant Zn²⁺-Phos-tag and HRP-SA, solution L (10 µl), an aqueous solution of 10 mM Zn(NO₃)₂ (20 µl), a commercially available solution of HRP-SA (1 µl), and TBS-T (469 µl) were mixed and allowed to stand for 30 min at room temperature. The mixed solution was put into a Microcon YM30 filter unit and centrifuged for 10 min at 14,000 x g to remove excess biotin-pendant Zn²⁺-Phos-tag. The remaining solution (<10 µl) in the reservoir was diluted with 30 ml of TBS-T solution and stored at 4 °C (Zn²⁺-Phos-tag-bound HRP-SA solution).

SDS-PAGE—
Polyacrylamide gel electrophoresis was conducted according to Laemmli’s method (12). Normal SDS-PAGE was usually performed at 35 mA/gel at room temperature in a 1-mm-thick, 9-cm-wide, and 9-cm-long gel on a PAGE apparatus (model AE6500; Atto, Tokyo, Japan). The gel consisted of 1.8 ml of a stacking gel (4.0% (w/v) polyacrylamide, 125 mM Tris-HCl (pH 6.8), and 0.1% (w/v) SDS) and 6.3 ml of a separating gel (7.5–12.5% (w/v) polyacrylamide, 375 mM Tris-HCl (pH 8.8), and 0.10% (w/v) SDS). For Mn²⁺-Phos-tag SDS-PAGE, acrylamide-pendant Phos-tag ligand (50–150 µM) and 2 eq of MnCl₂ were added to the separating gel before polymerization. An acrylamide stock solution was prepared as a mixture of a 29:1 ratio of acrylamide to N,N'-methylenebisacrylamide. The electrophoresis running buffer (pH 8.4) was 25 mM Tris and 192 mM glycine containing 0.1% (w/v) SDS. Sample proteins were resolved in an SDS-PAGE loading buffer (65 mM Tris-HCl (pH 6.8), 3.0% (w/v) SDS, 15% (v/v) 2-mercaptoethanol, 30% (v/v) glycerol, and 0.1% (w/v) bromphenol blue). The sample solutions were heated for 5 min at 95 °C before gel loading.

Pro-Q Diamond, SYPRO Ruby, and CBB Gel Staining—
After electrophoresis, gels were fixed in an aqueous solution containing 40% (v/v) MeOH and 10% (v/v) CH₃COOH for 30 min. To stain phosphorylated proteins with Pro-Q Diamond (10), the fixed gels were washed in water for 30 min, incubated with Pro-Q Diamond phosphoprotein gel stain for 3 h, and then washed in 50 mM CH₃COONa-CH₃COOH (pH 4.0) buffer containing 20% (v/v) CH₃CN for 3–12 h. For CBB staining, fixed gels were incubated with a CBB solution (0.1% (w/v) CBB, 10% (v/v) CH₃COOH, and 40% (v/v) MeOH) for 1 h and then washed in an aqueous solution containing 25% (v/v) MeOH and 10% (v/v) CH₃COOH until the background was clear. For SYPRO Ruby staining (11), fixed gels or Pro-Q Diamond-stained gels were incubated with SYPRO Ruby protein gel stain for 2 h and then washed in 25% (v/v) MeOH and 10% (v/v) CH₃COOH for 2 h.

Two-dimensional Polyacrylamide Gel Electrophoresis—
A431 cell lysate solved in a radioimmune precipitation assay buffer was desalted using Microcon YM3 filter units and resolved in a sample buffer for IEF (9.5 M urea, 2% (w/v) Nonidet P-40, 2% (w/v) Ampholine, and 5% (v/v) 2-mercaptoethanol) to become 2.5 µg of protein/µl. An IEF disc gel (2-mm diameter and 12 cm long) consisted of 9.2 M urea, 4% (w/v) acrylamide, 0.2% (w/v) N,N'-methylenebisacrylamide, 0.1% (v/v) TEMED, 1.5% (w/v) Nonidet P-40, 2% (w/v) Ampholine, and 0.015% (w/v) ammonium persulfate. IEF was performed using Atto SJ-1060DCII. The electrode buffer of positive pole (11 mM H₃PO₄, 0.75 liter) was poured into the lower chamber, and the disc gels were set. Sample solutions (50 µg of protein/20 µl) were applied, 20 µl of a sample protection buffer (4.5 M urea and 1% (w/v) Ampholine) was put on the sample layer, and electrode buffer of negative pole (25 mM NaOH, 450 ml) was poured into the upper chamber. IEF was carried out at 400 V for 16 h at room temperature without cooling. After IEF electrophoresis, a disc gel was soaked twice for 15 min with a 0.25 M Tris-HCl (pH 6.8) buffer containing 2.5% (w/v) SDS, 5% (v/v) 2-mercaptoethanol, and 10% (w/v) glycerol. And then SDS-PAGE (12.5% (w/v) polyacrylamide) was performed at 50 mA/gel at room temperature using a 1-mm-thick, 13.5-cm-wide, and 13.5-cm-long gel (model AE-6200, Atto).

Electroblotting—
The separated proteins in a polyacrylamide gel were electroblotted to PVDF membranes for 2 h using a semidry blotting system (Nippon Eido NB-1600, Tokyo, Japan) at 2 mA/cm² with three kinds of blotting solutions (solutions A, B, and C). After normal SDS-PAGE, the gel was soaked in solution B (25 mM Tris and 5% (v/v) MeOH) for 10 min. After Mn²⁺-Phos-tag SDS-PAGE, the gel was soaked in solution B containing 1.0 mM EDTA for 10 min and then soaked in solution B for 10 min. Three No. 3MM papers were soaked in solution A (25 mM Tris, 40 mM 6-aminohexanoic acid, and 5% (v/v) MeOH) and piled on the negative pole board. The gel, the PVDF membrane, and a piece of No. 3MM paper were soaked in solution B and piled up in order. Then two pieces of No. 3MM paper soaked in solution C (0.30 M Tris and 5% (v/v) MeOH) were piled up. Finally they were covered with the positive pole board, and electricity was supplied.

Probing with Zn²⁺-Phos-tag-bound HRP-SA—
A protein-blotted PVDF membrane was soaked in a TBS-T solution at least for 1 h. The membrane was incubated with the Zn²⁺-Phos-tag-bound HRP-SA solution (1 ml/5 cm²) in a plastic bag for 30 min and washed twice with a TBS-T solution (10 ml/5 cm²) for 5 min each time at room temperature. The chemiluminescence was observed using an appropriate volume of ECL Plus solution.

Probing with Antibody—
A blotting membrane was blocked by 1% (w/v) bovine serum albumin in TBS-T solution for 1 h. For detection of phosphorylated proteins on tyrosine residue, the membrane was probed with HRP-conjugated anti-Tyr(P) monoclonal antibody (clone PY20) (0.5 µg/ml in TBS-T, 1 ml/5 cm²) in a plastic bag for 1 h and washed twice with TBS-T solution (10 ml/5 cm²) each for 10 min, and then the chemiluminescence was observed. For detection of phosphorylated proteins on serine residue, the membrane was probed with rabbit anti-Ser(P) polyclonal antibody (1 µg/ml in TBS-T, 1 ml/5 cm²) in a plastic bag for 1 h, washed twice with TBS-T solution (10 ml/5 cm²) each for 10 min, probed with HRP-conjugated anti-rabbit IgG antibody (0.1 µg/ml in TBS-T, 1 ml/5 cm²) in a plastic bag for 1 h, and washed twice with TBS-T solution (10 ml/5 cm²) each for 10 min, and then the chemiluminescence was observed. For detection of phosphorylated MBP on threonine residue, the membrane was probed with anti-pMBP monoclonal antibody (clone P12) (0.5 µg/ml in TBS-T solution, 1 ml/5 cm²) in a plastic bag for 1 h, washed twice with TBS-T solution (10 ml/5 cm²) each for 10 min, probed with HRP-conjugated anti-mouse IgG antibody (0.1 µg/ml in TBS-T, 1 ml/5 cm²) in a plastic bag for 1 h, and washed twice with TBS-T solution (10 ml/5 cm²) each for 10 min, and then the chemiluminescence was observed. For phosphorylated MAP kinase 1/2 (Erk1/2) detection, the membrane was probed with anti-phospho-MAP kinase 1/2 antibody (clone 12D4) (0.1 µg/ml in TBS-T solution, 1 ml/5 cm²) in a plastic bag for 1 h, washed twice with TBS-T solution (10 ml/5 cm²) each for 10 min, probed with HRP-conjugated anti-mouse IgG antibody (0.1 µg/ml in TBS-T, 1 ml/5 cm²) in a plastic bag for 1 h, and washed twice with TBS-T solution (10 ml/5 cm²) each for 10 min, and then the chemiluminescence was observed.

Reprobing of the Blotting Membranes—
For elimination of biotin-pendant Zn²⁺-Phos-tag and HRP-SA or antibodies from the blotting membrane after ECL analysis, the membranes were incubated with a stripping buffer (25 ml/5 cm²) consisting of 62.5 mM Tris-HCl (pH 6.8), 2% (w/v) SDS, and 0.10 M 2-mercaptoethanol for 20 min at 50 °C and washed three times with TBS-T solution (25 ml/5 cm²) each for 1 h at room temperature, and remaining proteins on the membrane were probed with the other antibody.

Kinase Assays—
Phosphorylations of Abltide-GST catalyzed with Abl, MBP catalyzed with MAP kinase, and unactive MAP kinase 2/Erk2 catalyzed with MEK1 were performed using assay dilution buffer I (ADBI), magnesium/ATP mixture substrate solutions, and enzyme solutions obtained from Upstate Biotechnology without any dilutions. The component of each solution was as follows. ADBI consists of 20 mM MOPS (pH 7.2), 25 mM ß-glycerol phosphate, 5.0 mM EGTA, 1.0 mM sodium orthovanadate, and 1.0 mM dithiothreitol. Magnesium/ATP mixture consists of 75 mM MgCl₂ and 0.50 mM ATP in ADBI. Recombinant Abltide-GST (0.5 mg) was dissolved in 0.50 ml of 50 mM Tris-HCl (pH 8.0), 0.15 M NaCl, 20 mM glutathione, and 20% glycerol. MBP (2 mg) was dissolved in 1.0 ml of ADBI. Recombinant unactive MAP kinase 2/Erk2 (50 µg) was dissolved in 0.20 ml of 50 mM Tris-HCl (pH 7.5), 0.15 M NaCl, 0.10 mM EGTA, 0.03% Brij 35, 0.1% 2-mercaptoethanol, 1 mM benzamidine, 0.10 mM PMSF, and 50% glycerol. Recombinant Abl (5 µg) was dissolved in 50 µl of 50 mM Tris-HCl (pH 7.5), 0.27 M sucrose, 0.15 M NaCl, 1.0 mM benzamidine, 0.20 mM PMSF, 0.10 mM EGTA, 0.1% 2-mercaptoethanol, and 0.03% Brij 35. Recombinant MAP kinase 2/Erk2 (5 µg) was dissolved in 50 µl of 50 mM Tris-HCl (pH 7.5), 0.15 M NaCl, 0.10 mM EGTA, 0.03% Brij 35, 50% glycerol, 1.0 mM benzamidine, 0.20 mM PMSF, and 0.1% 2-mercaptoethanol. Recombinant MEK1 (5 µg) was dissolved in 50 µl of 50 mM Tris-HCl (pH 7.5), 0.10 mM EGTA, 0.15 M NaCl, 0.1% 2-mercaptoethanol, 0.03% Brij 35, 1.0 mM benzamidine, 0.20 mM PMSF, and 5% glycerol. Time-dependent phosphorylations of substrates were performed as follows. In the case of phosphorylation of Abltide-GST, 0.14 ml of ADBI, 39 µl of magnesium/ATP mixture, 20 µl of Abltide-GST (20 µg), and 1.0 µl of recombinant Abl (0.1 µg) were incubated at 30 °C. In the case of MBP, 29 µl of ADBI, 10 µl of magnesium/ATP mixture, 10 µl of MBP (20 µg), and 1.0 µl of recombinant MAP kinase 2/Erk2 (0.1 µg) were incubated at 30 °C. In recombinant unactive MAP kinase 2/Erk2, 148 µl of ADBI, 100 µl of magnesium/ATP mixture, 40 µl of recombinant unactive MAP kinase 2/Erk2 (10 µg), and 2 µl of recombinant MEK1 (0.2 µg) were incubated at 30 °C. Time-dependent phosphorylation of recombinant human histone H1.2 catalyzed with protein kinase A was performed in 50 µl of 50 mM Tris-HCl (pH 7.5), 10 mM MgCl₂, 0.20 mM ATP, 40 µg of histone H1.2, and 2,500 units of protein kinase A at 37 °C. The phosphorylation reactions were stopped by addition of a half-volume of 3x SDS-PAGE loading buffer. Zero time samples were prepared using the same components without the enzymes.

Phosphatase Assays—
Dephosphorylated samples of phosphoproteins were prepared using a 50 mM Tris-HCl buffer (pH 9.0, 0.20 ml) containing 1.0 mM MgCl₂, 50 µg of protein, and 3.3 units of alkaline phosphatase (incubation at 37 °C for 12 h and then mixing with 0.10 ml of 3x SDS-PAGE loading buffer). Time-dependent dephosphorylation of bovine milk ß-casein was performed in a 50 mM Tris-HCl buffer (pH 9.0, 0.14 ml) containing 1.0 mM MgCl₂, 0.7 mg of protein, and 165 microunits of alkaline phosphatase at 37 °C. Phosphorylated Abltide-GST was prepared as mentioned above, and the solution of the kinase reaction was used in the tyrosine phosphatase assay. Time-dependent dephosphorylation of phosphorylated Abltide-GST was performed in 50 mM Tris-HCl buffer (pH 7.0, 0.20 ml) containing 20 µl of phosphorylated Abltide-GST (2 µg) solution, and 0.3 unit of TC-PTP at 30 °C. The dephosphorylation reactions were stopped by addition of a half-volume of 3x SDS-PAGE loading buffer. Zero time samples were prepared using the same components without the enzymes.

	RESULTS

TOP ABSTRACT EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

 
Specific Visualization of Phosphorylated Proteins on a Blotting Membrane—
To visualize phosphorylated proteins, we determined the potency of biotin-pendant Zn²⁺-Phos-tag (9) (see Fig. 1) as a phosphate-binding biotin derivative for Western blotting analysis. As the first example, phosphorylated proteins (i.e. -casein, ß-casein, ovalbumin, and pepsin) spotted on a PVDF membrane were specifically detected at nanogram levels using an ECL system and a 4:1 complex of biotin-pendant Zn²⁺-Phos-tag and HRP-SA without a blocking treatment of the membrane. A typical ECL image by dot-blotting analysis is shown in Fig. 2a. No ECL signal was detected on the spots of the corresponding dephosphorylated proteins and the nonphosphorylated proteins (i.e. bovine serum albumin, human serum albumin, carbonic anhydrase, and ß-galactosidase). In the absence of the zinc(II) ions (i.e. using a 4:1 complex of biotin-pendant Phos-tag ligand and HRP-SA in the presence of 1 mM EDTA), no ECL signals were detected on the spots of phosphorylated proteins (data not shown). Thus, the phosphate-selective ECL signals were produced by the complex of biotin-pendant Zn²⁺-Phos-tag and HRP-SA via the interaction between the zinc(II) ions and the phosphomonoester dianion.

View larger version (29K): [in this window] [in a new window]   FIG. 2. Chemiluminescence detection of phosphorylated proteins on PVDF membranes using biotin-pendant Zn2+-Phos-tag and HRP-SA. a, dot-blotting analysis of four nonphosphorylated proteins (bovine serum albumin, human serum albumin, carbonic anhydrase, and ß-galactosidase), four phosphorylated proteins (-casein, ß-casein, ovalbumin, and pepsin), and the corresponding dephosphorylated proteins (AP-treated). b, electroblotting analysis of the phosphorylation of Abltide-GST (0.13 µg of protein/lane) incubated with a tyrosine kinase, Abl. c, electroblotting analysis of the dephosphorylation of phosphorylated Abltide-GST (50 ng of proteins/lane) incubated with a tyrosine phosphatase, TC-PTP. After elimination of biotin-pendant Zn2+-Phos-tag and HRP-SA from the membranes (b and c), the remaining phosphorylated Abltide-GST was probed using the HRP-anti-Tyr(P) antibody. The incubation time is shown above each lane. pTyr, phosphotyrosine.

Visualization of the Protein Phosphorylation Status of A431 Cells—
We extended the phosphate-specific detection to the analysis of the phosphorylation status of A431 human epidermoid carcinoma cells before and after EGF stimulation. The EGF-dependent protein phosphorylations in the A431 cell have been well established (13–23); therefore, we selected the cell as the first biological sample. For one-dimensional SDS-PAGE (Fig. 3, a–g), the molecular weight standards (lane M), the lysate of the cells before (lane 1) or after EGF stimulation (lane 2), and the AP-treated lysate of the cells after EGF stimulation (lane 3) were sequentially applied. Fluorescent gel staining with SYPRO Ruby (Fig. 3a) showed that the total proteins of the lysate applied in each lane were almost equal. Pro-Q Diamond gel staining (Fig. 3b) showed the increase of phosphorylated proteins by EGF stimulation and the decrease of dephosphorylated proteins by AP treatment. Electroblotting analysis using the 4:1 complex of biotin-pendant Zn²⁺-Phos-tag and HRP-SA (Fig. 3c) demonstrated that the ECL signals can represent the phosphorylation status of A431 cells more clearly than the fluorescent gel staining (Fig. 3b). The ECL signals increased by EGF stimulation (lane 2) were greatly diminished by AP treatment of the lysate (lane 3), indicating that the visualized proteins as ECL signals are phosphorylated proteins. The electroblotting analysis also detected a phosphorylated protein, ovalbumin (45 kDa), in the molecular weight standards (Fig. 3b, lane M). In electroblotting analysis using only HRP-SA, some proteins (e.g. a biotinylated endogenous protein) in the lysate were detected as ECL signals (Fig. 3d). Electroblotting analysis using the 4:1 complex of the biotin-pendant Phos-tag ligand and HRP-SA in the presence of 1 mM EDTA (Fig. 3e) showed, however, that the ECL signals (Fig. 3, c and d) disappeared completely. These facts suggested that the zinc(II) complexation and the binding of the biotin-pendant to HRP-SA are essential for phosphate-specific detection. The proteins of the cell lysate were also analyzed by immunoblotting using the anti-Tyr(P) antibody (Fig. 3f) and the anti-Ser(P) polyclonal antibody (Fig. 3g). With regard to monitoring the change in the phosphorylation status, the data of the blotting analysis using biotin-pendant Zn²⁺-Phos-tag were compatible with these results obtained with conventional methods using antibodies. In all electroblotting analyses, a nonspecific ECL signal of a marker protein, lysozyme (14 kDa in lane M), was observed using the ECL system (Fig. 3, c–g).

View larger version (50K): [in this window] [in a new window]   FIG. 3. Comparison of different detection methods for one-dimensional SDS-PAGE (a–g) and 2-D IEF/SDS-PAGE (h–j) of A431 cell lysate. a, fluorescent gel staining with SYPRO Ruby (i.e. staining of all proteins). b, fluorescent gel staining with Pro-Q Diamond (i.e. staining of the phosphorylated protein). c, electroblotting analysis (chemiluminescence detection) using biotin-pendant Zn2+-Phos-tag and HRP-SA. d, electroblotting analysis (chemiluminescence detection) using HRP-SA. e, electroblotting analysis (chemiluminescence detection) using the HRP-SA complex with the biotin-pendant Phos-tag ligand in the presence of 1 mM EDTA. f, electroblotting analysis (chemiluminescence detection) using the HRP-anti-Tyr(P) antibody. g, electroblotting analysis (chemiluminescence detection) using the anti-Ser(P) antibody and the HRP-anti-IgG antibody. Each lane (a–g) contains 7.5 µg of protein of the A431 cell lysate before (lane 1) or after (lane 2) EGF stimulation or 7.5 µg of protein of the AP-treated lysate of EGF-stimulated A431 cells (lane 3). The molecular mass standards (205, 116, 97, 80, 66, 55, 45 (ovalbumin), 30, 21, and 14 (lysozyme) kDa from the top) are shown in lane M. h, electroblotting 2-D analysis (chemiluminescence detection) of the EGF-stimulated A431 cell lysate (50 µg of proteins) using biotin-pendant Zn2+-Phos-tag and HRP-SA. The blot was successively probed with the HRP-anti-Tyr(P) antibody and the anti-Ser(P) antibody/HRP-anti-IgG antibody. Shown are superimposed images of the area surrounded with a dotted square in h: i, using biotin-pendant Zn2+-Phos-tag (green) and the anti-Tyr(P) antibody (magenta); j, using biotin-pendant Zn2+-Phos-tag (green) and the anti-Ser(P) antibody (magenta). Proteins detected by both methods appear as white spots in i and j. pSer, phosphoserine; pTyr, phosphotyrosine.

Separation of Phosphorylated Proteins in a Polyacrylamide Gel—
We synthesized an acrylamide-pendant Phos-tag ligand (see Fig. 1 and "Experimental Procedures") as a novel additive (i.e. a copolymer) of the separating gel for the visualization of phosphorylated proteins by SDS-PAGE. The principle of this detection is the mobility shift of phosphorylated proteins due to reversible phosphate trapping by Phos-tag molecules immobilized in the gel. First we applied a polyacrylamide-bound Zn²⁺-Phos-tag to SDS-PAGE according to the widely accepted Laemmli method (12). However, the expected phosphate-selective mobility shift was not observed under such general SDS-PAGE conditions (data not shown). Presumably the alkaline condition (more than pH 9 during the electrophoresis) is beyond the optimum pH (7) for the phosphate trapping of Zn²⁺-Phos-tag (4). Therefore, we investigated the other metal complex acting as a phosphate-trapping molecule at an alkaline pH. The phosphate binding of the Phos-tag metal complex at pH 9 was confirmed by MALDI-TOF-MS using phenyl phosphate, phosphoserine, and phosphotyrosine as typical phosphates (ROPO₃^2–) in the presence of 2 eq. of metal(II) ions (i.e. Mn²⁺, Cu²⁺, Co²⁺, Fe²⁺, and Ni²⁺). The acrylamide-pendant Phos-tag ligand showed remarkable MS signals of the 1:1 phosphate-binding manganese(II) complexes (i.e. ROPO₃^2–-[acrylamide-pendant Mn²⁺-Phos-tag]³⁺, see Supplemental Fig. 3). Similar MALDI-TOF-MS signals for corresponding 1:1 phosphate complexes with Zn²⁺-Phos-tag have been reported at a neutral pH (5).

On the basis of the MALDI-TOF-MS results, we conducted SDS-PAGE using polyacrylamide-bound Mn²⁺-Phos-tag. Fig. 4 shows the effect of Mn²⁺-Phos-tag on the mobility of phosphorylated proteins (-casein, ß-casein, and ovalbumin) in SDS-PAGE by subsequent CBB staining. In the absence of polyacrylamide-bound Mn²⁺-Phos-tag (i.e. normal SDS-PAGE), the mobilities of -casein and dephosphorylated -casein (Fig. 4a, lane at 0 µM), of ß-casein and dephosphorylated ß-casein (Fig. 4b, lane at 0 µM), and of ovalbumin and dephosphorylated ovalbumin (Fig. 4c, lane at 0 µM) are almost the same. In the presence of polyacrylamide-bound Mn²⁺-Phos-tag (50, 100, and 150 µM), a difference in mobility between the phosphorylated proteins and the corresponding dephosphorylated proteins (i.e. a mobility shift of the phosphorylated protein against the dephosphorylated protein) is observed. The polyacrylamide-bound Phos-tag ligand without Mn²⁺ ions did not show any mobility shifts of phosphorylated proteins (data not shown). The R_f values of all samples become smaller dose-dependently in comparison with those in the absence of Mn²⁺-Phos-tag; this is possibly due to electrostatic interaction between cationic Mn²⁺-Phos-tag and anionic SDS-bound proteins. Interestingly ß-casein appears as eight bands using 100 µM Mn²⁺-Phos-tag (see Fig. 4b), indicating the existence of at least eight isotypes with a different number of phosphomonoester dianions.

View larger version (25K): [in this window] [in a new window]   FIG. 4. SDS-PAGE of phosphorylated proteins and the corresponding dephosphorylated proteins in the absence and presence of polyacrylamide-bound Mn2+-Phos-tag (50, 100, and 150 µM). a, -casein with 10% polyacrylamide gel. b, ß-casein with 10% polyacrylamide gel. c, ovalbumin with 7.5% polyacrylamide gel. The phosphorylated and dephosphorylated proteins (0.30 µg of protein/lane) were applied in the left and right lanes, respectively, for each run of electrophoresis. The Rf value of 1.0 is defined as the position of bromphenol blue dye. All SDS-PAGE gels were stained with CBB dye.

View larger version (27K): [in this window] [in a new window]   FIG. 5. Kinase and phosphatase assays by Mn2+-Phos-tag SDS-PAGE (10–12.5% polyacrylamide containing 100 µM polyacrylamide-bound Mn2+-Phos-tag). a, phosphorylation of Abltide-GST (0.10 µg of protein/lane) incubated with Abl in 12.5% polyacrylamide gel. After Mn2+-Phos-tag SDS-PAGE, immunoblotting analysis (chemiluminescence detection) was conducted using the HRP-anti-Tyr(P) antibody. b, phosphorylation of MBP (0.56 µg of protein/lane) incubated with MAP kinase in 12.5% polyacrylamide gel. After Mn2+-Phos-tag SDS-PAGE, immunoblotting analysis (chemiluminescence detection) was conducted using the anti-pMBP antibody/HRP-anti-IgG antibody. c, dephosphorylation of ß-casein (0.30 µg of protein/lane) incubated with AP in 10% polyacrylamide gel. d, dephosphorylation of phosphorylated Abltide-GST (0.10 µg of protein/lane) incubated with a tyrosine phosphatase, TC-PTP, in 12.5% polyacrylamide gel. The incubation time is shown above each lane. Normal SDS-PAGE and Mn2+-Phos-tag SDS-PAGE gels were stained with CBB dye.

	DISCUSSION

TOP ABSTRACT EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

The biotin-pendant Zn²⁺-Phos-tag was reported as a novel probe of multiphosphopeptides to detect the on-chip phosphorylations by the SPR imaging technique (9). Previously another SPR detection system with the anti-Tyr(P) antibody was proposed (24). Antibodies whose epitopes are Ser(P), Thr(P), or Tyr(P) are commercially available and can be applied to phosphorylation detection on the SPR. However, multiple antibodies are required for the peptide array on which many kinase substrates are immobilized. Therefore, the Phos-tag molecule, which is not dependent on the amino acid residue, was very useful in a system with an array format. In a similar fashion, it is worthwhile to consider using the biotin-pendant Zn²⁺-Phos-tag in Western blotting analysis for evaluating whole phosphorylated proteins from the cell lysate on a PVDF membrane. In addition, the application can increase the chances of finding a new phosphorylated protein. Classical detection of phosphorylated proteins usually requires the use of autoradiography after the incorporation of isotopic [³²P]orthophosphate into cultured cells or subcellular fractions by protein kinases (14–21). However, this approach is limited to specimens amenable to radiolabeling and poses certain safety and disposal problems. Furthermore phosphorylated proteins on a PVDF membrane can be detected by immunoblotting analysis using antibodies against phosphorylated amino acid residues (25–27). Unfortunately the specificity of antibodies depends on the quality of the antibody, and the antibodies are often sensitive to the amino acid sequence context. Although a few high quality clones of antibodies to phosphorylated tyrosine are commercially available, the binding specificities of some anti-Ser(P) and anti-Thr(P) antibodies are dependent on the microenvironmental structures of phosphorylated residues in the proteins. Compared with these traditional approaches, our established method offers significant advantages. (i) The radioactivity is avoided. (ii) The blocking treatment of a PVDF membrane is not necessary. (iii) The binding specificity of the Phos-tag molecule is independent of the amino acid sequence context. Furthermore the Phos-tag method can be fully followed by downstream procedures, such as antibody reprobing, mass spectrometry, or Edman sequencing.

The Mn²⁺-Phos-tag was utilized as a novel phosphate affinity SDS-PAGE. The polyacrylamide-bound Mn²⁺-Phos-tag showed preferential trapping of the phosphorylated proteins without disordering (waving or tailing of protein bands) of the migration image. The 1:1 phosphate-bound Mn²⁺-Phos-tag complexes were confirmed by MALDI-TOF-MS at an alkaline pH for the general SDS-PAGE. A relevant x-ray crystal structure of the dimanganese complex with the Phos-tag ligand (alkoxide form) was reported as an acetate-bridging species (28). Our established method requires a general minislab PAGE system and an additive, acrylamide-pendant Mn²⁺-Phos-tag without any special apparatuses, radioisotopes, or fluorescent probes. The Mn²⁺-Phos-tag SDS-PAGE can identify the time course ratio of phosphorylated and dephosphorylated proteins in an SDS-PAGE gel.

The phosphorylation status of a particular protein is determined by the equilibrium of the opposing activities of protein kinase and phosphatase. Perturbations in the equilibrium fundamentally affect the numbers of cellular events and are also involved in many diseases. Therefore, the development of a more specific and efficient method to detect protein phosphorylation has attracted great interest toward phosphoproteome studies in the biological and medical fields. We believe that phosphoproteomics would progress greatly by combining our Phos-tag technology and existing methods using high quality antibodies (27) and convenient mass spectrometers (3, 29, 30).

	FOOTNOTES

 
Received, September 20, 2005, and in revised form, November 4, 2005.

Published, MCP Papers in Press, December 11, 2005, DOI 10.1074/mcp.T500024-MCP200

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

¹ The abbreviations used are: Phos-tag, phosphate-binding tag; AP, alkaline phosphatase; EGF, epidermal growth factor; HRP, horseradish peroxidase; HRP-SA, horseradish peroxidase-conjugated streptavidin; TC-PTP, T-cell protein tyrosine phosphatase; SPR, surface plasmon resonance; CBB, Coomassie Brilliant Blue R-250; TEMED, N,N,N',N'-tetramethylethylenediamine; MAP, mitogen-activated protein; MBP, myelin basic protein; pMBP, phospho-MBP; HL, metal-free ligand; ADBI, assay dilution buffer I; 2-D, two-dimensional.

^* This work was supported by Grants-in-aid for Scientific Research (B) 15390013 and for Young Scientists (B) 17790034 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by a research grant from Hiroshima University Fujii Foundation.

^S The on-line version of this article (available at http://www.mcponline.org) contains supplemental material.

^|| To whom correspondence may be addressed. Tel.: 81-82-257-5281; Fax: 81-82-257-5336; E-mail: tkoike{at}hiroshima-u.ac.jp

^¶ To whom correspondence may be addressed. Tel.: 81-82-257-5281; Fax: 81-82-257-5336; E-mail: kinoeiji{at}hiroshima-u.ac.jp

	REFERENCES

TOP ABSTRACT EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

 

1. Hunter, T. (1995) Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell 80, 225 –236[CrossRef][Medline]

2. Hunter, T. (2000) Signaling—2000 and beyond. Cell 100, 113 –127[CrossRef][Medline]

3. Ohtsu, I., Nakanishi, T., Furuta, M., Ando, E., and Nishimura, O. (2005) Direct matrix-assisted laser desorption/ionization time-of-flight mass spectrometric identification of proteins on membrane detected by western blotting and lectin blotting. J. Proteome Res. 4, 1391 –1396[CrossRef][Medline]

4. Kinoshita, E., Takahashi, M., Takeda, H., Shiro, M., and Koike T. (2004) Recognition of phosphate monoester dianion by an alkoxide-bridged dinuclear zinc(II) complex. Dalton Trans.1189–1193

5. Takeda, H., Kawasaki, A., Takahashi, M., Yamada, A., and Koike, T. (2003) Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry of phosphorylated compounds using a novel phosphate capture molecule. Rapid Commun. Mass Spectrom. 17, 2075 –2081[CrossRef][Medline]

6. Hirano, K., Matsui, H., Tanaka, T., Matsuura, F., Satouchi, K., and Koike, T. (2004) Production of 1,2-didocosahexaenoyl phosphatidylcholine by bonito muscle lysophosphatidylcholine/transacylase. J. Biochem. (Tokyo) 136, 477 –483[Abstract/Free Full Text]

7. Tanaka, T., Tsutsui, H., Hirano, K., Koike, T., Tokumura, A., and Satouchi, K. (2004) Quantitative analysis of lysophosphatidic acid by time-of-flight mass spectrometry using a phosphate-capture molecule. J. Lipid Res. 45, 2145 –2150[Abstract/Free Full Text]

8. Kinoshita, E., Yamada, A., Takeda, H., Kinoshita-Kikuta, E., and Koike, T. (2005) Novel immobilized zinc(II) affinity chromatography for phosphopeptides and phosphorylated proteins. J. Sep. Sci. 28, 155 –162[CrossRef][Medline]

9. Inamori, K., Kyo, M., Nishiya, Y., Inoue, Y., Sonoda, T., Kinoshita, E., Koike, T., and Katayama, Y. (2005) Detection and quantification of on-chip phosphorylated peptides by surface plasmon resonance imaging techniques using a phosphate capture molecule. Anal. Chem. 77, 3979 –3985[Medline]

10. Steinberg, T. H., Agnew, B. J., Gee, K. R., Leung, W. Y., Goodman, T., Schulenberg, B., Hendrickson, J., Beechem, J. M., Haugland, R. P., and Patton, W. F. (2003) Global quantitative phosphoprotein analysis using multiplexed proteomics technology. Proteomics 3, 1128 –1144[CrossRef][Medline]

11. Berggren, K., Chernokalskaya, E., Steinberg, T. H., Kemper, C., Lopez, M. F., Diwu, Z., Haugland, R. P., and Patton, W. F. (2000) Background-free, high sensitivity staining of proteins in one- and two-dimensional sodium dodecyl sulfate-polyacrylamide gels using a luminescent ruthenium complex. Electrophoresis 21, 2509 –2521[CrossRef][Medline]

12. Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680 –685[CrossRef][Medline]

13. Carpenter, G., and Cohen, S. (1979) Epidermal growth factor. Annu. Rev. Biochem. 48, 193 –216[CrossRef][Medline]

14. Carpenter, G., King, L., Jr., and Cohen, S. (1979) Rapid enhancement of protein phosphorylation in A-431 cell membrane preparations by epidermal growth factor. J. Biol. Chem. 254, 4884 –4891[Abstract/Free Full Text]

15. Cohen, S., Carpenter, G., and King, L., Jr. (1980) Epidermal growth factor-receptor-protein kinase interactions. Co-purification of receptor and epidermal growth factor-enhanced phosphorylation activity. J. Biol. Chem. 255, 4834 –4842[Abstract/Free Full Text]

16. Linsley, P. S., and Fox, C. F. (1980) Controlled proteolysis of EGF receptors: evidence for transmembrane distribution of the EGF binding and phosphate acceptor sites. J. Supramol. Struct. 14, 461 –471[CrossRef][Medline]

17. Hunter, T., and Cooper, J. A. (1981) Epidermal growth factor induces rapid tyrosine phosphorylation of proteins in A431 human tumor cells. Cell 24, 741 –752[CrossRef][Medline]

18. Cooper, J. A., and Hunter, T. (1981) Similarities and differences between the effects of epidermal growth factor and Rous sarcoma virus. J. Cell Biol. 91, 878 –883[Abstract/Free Full Text]

19. Ghosh-Dastidar, P., and Fox, C. F. (1983) Epidermal growth factor and epidermal growth factor receptor-dependent phosphorylation of a M_r = 34,000 protein substrate for pp60^src. J. Biol. Chem. 258, 2041 –2044[Abstract/Free Full Text]

20. Meisenhelder, J., Suh, P. G., Rhee, S. G., and Hunter, T. (1989) Phospholipase C- is a substrate for the PDGF and EGF receptor protein-tyrosine kinases in vivo and in vitro. Cell 57, 1109 –1122[CrossRef][Medline]

21. Li, S., Couvillon, A. D., Brasher, B. B., and Van Etten, R. A. (2001) Tyrosine phosphorylation of Grb2 by Bcr/Abl and epidermal growth factor receptor: a novel regulatory mechanism for tyrosine kinase signaling. EMBO J. 20, 6793 –6804[CrossRef][Medline]

22. Lim, Y. P., Diong, L. S., Qi, R., Druker, B. J., and Epstein, R. J. (2003) Phosphoproteomic fingerprinting of epidermal growth factor signaling and anticancer drug action in human tumor cells. Mol. Cancer Ther. 2, 1369 –1377[Abstract/Free Full Text]

23. Chelius, D., Zhang, T., Wang, G., and Shen, R. F. (2003) Global protein identification and quantification technology using two-dimensional liquid chromatography nanospray mass spectrometry. Anal. Chem. 75, 6658 –6665[Medline]

24. Houseman, B. T., Huh, J. H., Kron, S. J., and Mrksich, M. (2002) Peptide chips for the quantitative evaluation of protein kinase activity. Nat. Biotechnol. 20, 270 –274[CrossRef][Medline]

25. Czernik A. J., Girault, J. A., Nairn, A. C., Chen, J., Snyder, G., Kebabian, J., and Greengard, P. (1991) Production of phosphorylation state-specific antibodies. Methods Enzymol. 201, 264 –283[Medline]

26. Epstein, R. J., Druker, B. J., Roberts, T. M., and Stiles, C. D. (1992) Synthetic phosphopeptide immunogens yield activation-specific antibodies to the c-erbB-2 receptor. Proc. Natl. Acad. Sci. U. S. A. 89, 10435 –10439[Abstract/Free Full Text]

27. Kaufmann, H., Bailey, J. E., and Fussenegger, M. (2001) Use of antibodies for detection of phosphorylated proteins separated by two-dimensional gel electrophoresis. Proteomics 1, 194 –199[CrossRef][Medline]

28. Suzuki, M., Sugisawa, T., Senda, H., Oshio, H., and Uehara, A. (1989) Synthesis and characterization of a novel tetranuclear manganese(II,III,III,II) mixed valence complex. Chem. Lett.1091 –1094

29. Sloane, A. J., Duff, J. L., Wilson, N. L., Gandhi, P. S. Hill, C. J., Hopwood, F. G. Smith, P. E., Thomas, M. L., Cole, R. A., Packer, N. H., Breen, E. J., Cooley, P. W., Wallace, D. B., Williams, K. L., and Gooley, A. A. (2002) High throughput peptide mass fingerprinting and protein macroarray analysis using chemical printing strategies. Mol. Cell. Proteomics 1, 490 –499[Abstract/Free Full Text]

30. Nakanishi, T., Ohtsu, I., Furuta, M., Ando, E., and Nishimura, O. (2005) Direct MS/MS analysis of proteins blotted on membranes by a matrix-assisted laser desorption/ionization-quadrupole ion trap-time-of-flight tandem mass spectrometer. J. Proteome Res. 4, 743 –747[CrossRef][Medline]

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				K. Takeya, K. Loutzenhiser, M. Shiraishi, R. Loutzenhiser, and M. P. Walsh A highly sensitive technique to measure myosin regulatory light chain phosphorylation: the first quantification in renal arterioles Am J Physiol Renal Physiol, June 1, 2008; 294(6): F1487 - F1492. [Abstract] [Full Text] [PDF]

				A. Devault, E. Gueydon, and E. Schwob Interplay between S-Cyclin-dependent Kinase and Dbf4-dependent Kinase in Controlling DNA Replication through Phosphorylation of Yeast Mcm4 N-Terminal Domain Mol. Biol. Cell, May 1, 2008; 19(5): 2267 - 2277. [Abstract] [Full Text] [PDF]

				K. Tatematsu, N. Yoshimoto, T. Okajima, K. Tanizawa, and S. Kuroda Identification of Ubiquitin Ligase Activity of RBCK1 and Its Inhibition by Splice Variant RBCK2 and Protein Kinase C{beta} J. Biol. Chem., April 25, 2008; 283(17): 11575 - 11585. [Abstract] [Full Text] [PDF]

				S.-i. Inoue, T. Kinoshita, M. Matsumoto, K. I. Nakayama, M. Doi, and K.-i. Shimazaki Blue light-induced autophosphorylation of phototropin is a primary step for signaling PNAS, April 8, 2008; 105(14): 5626 - 5631. [Abstract] [Full Text] [PDF]

				H. Oh and K. D. Irvine In vivo regulation of Yorkie phosphorylation and localization Development, March 15, 2008; 135(6): 1081 - 1088. [Abstract] [Full Text] [PDF]

				R. G. Uhrig, B. O'Leary, H. E. Spang, J. A. MacDonald, Y.-M. She, and W. C. Plaxton Coimmunopurification of Phosphorylated Bacterial- and Plant-Type Phosphoenolpyruvate Carboxylases with the Plastidial Pyruvate Dehydrogenase Complex from Developing Castor Oil Seeds Plant Physiology, March 1, 2008; 146(3): 1346 - 1357. [Abstract] [Full Text] [PDF]

				E. Kinoshita-Kikuta, Y. Aoki, E. Kinoshita, and T. Koike Label-free Kinase Profiling Using Phosphate Affinity Polyacrylamide Gel Electrophoresis Mol. Cell. Proteomics, February 1, 2007; 6(2): 356 - 366. [Abstract] [Full Text] [PDF]

This Article